Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Entrada Therapeutics, Inc. is a biopharmaceutical company focused on developing intracellular therapeutics using its proprietary Endosomal Escape Vehicle (EEV) platform. The company advances treatments for rare neuromuscular diseases, genetic disorders, and ocular conditions by enabling targeted delivery of nucleic acids, proteins, and other molecules into cells. Its portfolio includes clinical-stage candidates for Duchenne muscular dystrophy, myotonic dystrophy, and other diseases, leveraging innovative delivery technologies to address unmet medical needs.
This description was generated via AI from an annual report. Updated about 1 year ago.